ATE135230T1 - Zusammensetzung und behandlung mit biologisch aktiven peptiden und antibiotika - Google Patents

Zusammensetzung und behandlung mit biologisch aktiven peptiden und antibiotika

Info

Publication number
ATE135230T1
ATE135230T1 AT90906603T AT90906603T ATE135230T1 AT E135230 T1 ATE135230 T1 AT E135230T1 AT 90906603 T AT90906603 T AT 90906603T AT 90906603 T AT90906603 T AT 90906603T AT E135230 T1 ATE135230 T1 AT E135230T1
Authority
AT
Austria
Prior art keywords
biologically active
antibiotics
composition
peptide
antibiotic
Prior art date
Application number
AT90906603T
Other languages
English (en)
Inventor
Michael Zasloff
Barry Berkowitz
Original Assignee
Philadelphia Children Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philadelphia Children Hospital filed Critical Philadelphia Children Hospital
Application granted granted Critical
Publication of ATE135230T1 publication Critical patent/ATE135230T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT90906603T 1989-04-17 1990-04-11 Zusammensetzung und behandlung mit biologisch aktiven peptiden und antibiotika ATE135230T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33929289A 1989-04-17 1989-04-17
US07/402,642 US5254535A (en) 1989-04-17 1989-09-05 Composition and treatment with biologically active peptides and antibiotic

Publications (1)

Publication Number Publication Date
ATE135230T1 true ATE135230T1 (de) 1996-03-15

Family

ID=26991557

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90906603T ATE135230T1 (de) 1989-04-17 1990-04-11 Zusammensetzung und behandlung mit biologisch aktiven peptiden und antibiotika

Country Status (12)

Country Link
US (1) US5254535A (de)
EP (1) EP0469036B1 (de)
JP (1) JPH04507087A (de)
KR (1) KR920700042A (de)
CN (1) CN1046462A (de)
AT (1) ATE135230T1 (de)
AU (1) AU5439490A (de)
CA (1) CA2013738A1 (de)
DE (1) DE69025927T2 (de)
DK (1) DK0469036T3 (de)
IL (1) IL93959A0 (de)
WO (1) WO1990012587A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ237202A (en) * 1990-02-23 1994-01-26 Bristol Myers Squibb Co Composition containing beta-lactam antibiotic and cationic oligopeptide
AU648140B2 (en) * 1991-02-01 1994-04-14 Virtual Drug Development, Inc. Reverse antimicrobial peptides and antimicrobial compositions
US5593866A (en) * 1992-08-21 1997-01-14 The University Of British Columbia Cationic peptides and method for production
WO1994019369A1 (en) * 1993-02-26 1994-09-01 Magainin Pharmaceuticals, Inc. Treatment of cancerous growths with biologically active peptides and protease inhibitors
WO1994028921A1 (en) * 1993-06-04 1994-12-22 Demeter Biotechnologies, Ltd. Method of treating pulmonary disease states with non-naturally occurring amphipathic peptides
US5834430A (en) * 1995-05-31 1998-11-10 Biosynth S.R.L. Potentiation of antibiotics
US6057291A (en) 1995-06-02 2000-05-02 University Of British Columbia Antimicrobial cationic peptides
DE69637731D1 (de) 1995-08-23 2008-12-11 Univ British Columbia Antimikrobielle kationische peptide und methoden zu ihrer identifizierung
US8003595B2 (en) 2000-03-01 2011-08-23 Cellectis Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
US20040072815A1 (en) * 2002-02-12 2004-04-15 Koppel Gary A. Antibiotic composition and method
EP1360961A1 (de) * 2002-05-07 2003-11-12 AM-Pharma B.V. Verwendung von antimikrobiell wirkenden Peptiden zur Aktivitätssteigerung von antimikrobiellen Wirkstoffen
WO2005016960A2 (en) * 2003-08-14 2005-02-24 Diatos Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
FR2858772A1 (fr) * 2003-08-14 2005-02-18 Diatos Composition anti bacterienne, plus particulierement contre les bacteries gram negatif, comprenant un peptide et un agent anti-bacterien avantageusement hydrophobe
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
WO2010075416A1 (en) 2008-12-23 2010-07-01 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
GB201616014D0 (en) * 2016-09-20 2016-11-02 Helperby Therapeutics Ltd Combination
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
CN114432428B (zh) * 2022-02-24 2024-07-23 西北农林科技大学 PGLa提高细菌对抗生素的敏感性和延缓细菌耐药性产生的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE436645C (sv) * 1976-04-29 1996-07-22 Bonnierfoeretagen Ab Antigeniskt aktiv polypeptid, som kan användas vid cancerdiagnosticering och vid framställning av antikroppar
US4659692A (en) * 1982-11-19 1987-04-21 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
DE3324534A1 (de) * 1983-07-07 1985-01-17 Ciba-Geigy Ag, Basel Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel
US4617149A (en) * 1983-09-21 1986-10-14 Eli Lilly And Company Growth hormone release factor analogs
DE3438296A1 (de) * 1984-04-18 1985-11-07 Hoechst Ag, 6230 Frankfurt Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel
EP0209061B1 (de) * 1985-07-17 1994-01-12 Hoechst Aktiengesellschaft Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel
AU609118B2 (en) * 1987-03-04 1991-04-26 United States of America, as represented by the Secretary, U.S. Department of Commerce, The New synthetic bioactive compounds and method of producing bioactive effect

Also Published As

Publication number Publication date
KR920700042A (ko) 1992-02-19
DE69025927T2 (de) 1996-08-01
EP0469036B1 (de) 1996-03-13
CN1046462A (zh) 1990-10-31
CA2013738A1 (en) 1990-10-17
EP0469036A1 (de) 1992-02-05
JPH04507087A (ja) 1992-12-10
WO1990012587A1 (en) 1990-11-01
US5254535A (en) 1993-10-19
IL93959A0 (en) 1990-12-23
AU5439490A (en) 1990-11-16
DE69025927D1 (de) 1996-04-18
DK0469036T3 (da) 1996-04-01
EP0469036A4 (en) 1992-07-08

Similar Documents

Publication Publication Date Title
DE69025927D1 (de) Zusammensetzung und behandlung mit biologisch aktiven peptiden und antibiotika
BG104370A (en) Composition improving the penetration into the skin
DK0695759T3 (da) Peptapeptid-methylestere, der inhiberer human cancer
ATE218582T1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen
DK0720482T3 (da) Prosaposin og cytokin-afledte peptider som terapeutiske midler
DE69001876D1 (de) Hoch-resorbierbare transvaginale zubereitung mit biologisch aktiven peptiden.
MX9803344A (es) Formulacion farmaceutica liofilizada, estable.
NO974618L (no) Farmasöytiske preparater for intranasal administrasjon
ATE218580T1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen
ES2136599T3 (es) Tratamiento de las heridas utilizando peptidos biologicamente activos.
CA2378503A1 (en) Manufacture and use of an antibiotic/antibiotics(or: antibiotic(s)) preparation
EA199900751A1 (ru) Фармацевтическая композиция, содержащая лиофилизированные липосомы, включающие инкапсулированный активный ингредиент, практически нерастворимый в воде, и способ получения композиции
RU94046091A (ru) Полипептидные антагонисты бомбезина, фармацевтическая композиция и способ лечения
MY103769A (en) Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients
ATE281155T1 (de) Medikamentöse verabreichung von proteinen aus polymergemischen
EE03224B1 (et) Prolongeeritud toimega süstesuspensioonid ja nende valmistamismeetod
RU94040150A (ru) Стабильная лиофилизированная композиция тиотепа, способ ее получения
AU3769189A (en) Amphiphilic peptides and use thereof
DE69621591D1 (de) Medikament welches Protein C aktivierendes Peptid enthält
KR900701300A (ko) 생물학적 활성 펩티드 및 특정음이온을 갖는 조성물 및 이것을 사용하는 방법
EP0914826A4 (de) Mittel zur beschleunigung der wundheilung
RU94040865A (ru) Производные пептида и их терапевтически приемлемые соли, способ их получения, фармацевтическая и косметическая композиция с антивирусной активностью
KR900701299A (ko) Cpf 펩티드 조성물 및 이를 사용하는 방법
PT93684A (pt) Processo de composicao e tratamento com peptidios biologicamente activos e antibioticos
EP0326067A3 (de) Verwendung von Cyclophylin als Entzündungshemmer und Immunmodulator

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee